These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 339045

  • 1. [Influence of (+)-cyanidanol-3 on acute hepatitis. Results of a double blind study (author's transl)].
    Rehmann I, Heinkel K.
    Med Klin; 1977 Dec 16; 72(50):2159-64. PubMed ID: 339045
    [Abstract] [Full Text] [Related]

  • 2. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
    Magliulo E, Gagliardi B, Fiori GP.
    Med Klin; 1978 Jul 14; 73(28-29):1060-5. PubMed ID: 353464
    [Abstract] [Full Text] [Related]

  • 3. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I, Schmidt FW, Müller R, Ranft U, Wildhirt E, Holzer E, Wallnöfer H, Korb G.
    Dtsch Med Wochenschr; 1980 Mar 07; 105(10):330-2. PubMed ID: 6153953
    [Abstract] [Full Text] [Related]

  • 4. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E, Leodolter I, Thaler H.
    Leber Magen Darm; 1977 Oct 07; 7(5):318-23. PubMed ID: 926982
    [Abstract] [Full Text] [Related]

  • 5. [Effect of (+)-cyanidanol-3 in the treatment of chronic active hepatitis (author's transl)].
    Demeulenaere F, Desmet VJ, Dupont E, Fiasse R, Gisselbrecht H, Heully F, Jeanpierre R, Lecomte J, Lennes G, Macinot C, Migeotte P, Pirotte J, Rauber G, Ruyters L, Van Cauwenberge H.
    Gastroenterol Clin Biol; 1981 Mar 07; 5(3):314-23. PubMed ID: 7014344
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW, Haase W.
    Schweiz Rundsch Med Prax; 1975 Sep 09; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984 Sep 09; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients.
    Shumaker JB, Resnick RH, Galambos JT, Makopour H, Iber FL.
    Am J Gastroenterol; 1978 Apr 09; 69(4):443-9. PubMed ID: 356593
    [Abstract] [Full Text] [Related]

  • 14. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C, Petrea S, Băldescu R, Macarie E, Chiriloiu C, Purice S.
    Med Interne; 1988 Apr 09; 26(4):311-22. PubMed ID: 3072661
    [Abstract] [Full Text] [Related]

  • 15. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
    Depew W, Boyer T, Omata M, Redeker A, Reynolds T.
    Gastroenterology; 1980 Mar 09; 78(3):524-9. PubMed ID: 6985881
    [Abstract] [Full Text] [Related]

  • 16. Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials.
    Rambaldi A, Jacobs BP, Iaquinto G, Gluud C.
    Am J Gastroenterol; 2005 Nov 09; 100(11):2583-91. PubMed ID: 16279916
    [Abstract] [Full Text] [Related]

  • 17. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF, Di Martino V, Dorent R, Bernard B, Hoang C, Myara A, Pauwels A, Ghoussoub JJ, Perrin M, Grippon P, Thabut D, Trivin F, Huraux JM, Gandjbakhch I, Opolon P, Lunel F.
    Transplantation; 2003 Apr 15; 75(7):977-82. PubMed ID: 12698083
    [Abstract] [Full Text] [Related]

  • 18. Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial.
    Nilius R, Schentke U, Otto L, Teichmann W, Zipprich B, Schmidt W, Brügmann E, Busse HJ.
    Hepatogastroenterology; 1983 Jun 15; 30(3):90-2. PubMed ID: 6350136
    [Abstract] [Full Text] [Related]

  • 19. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ, Borg R.
    Minerva Dietol Gastroenterol; 1977 Jun 15; 23(3):237-42. PubMed ID: 372845
    [No Abstract] [Full Text] [Related]

  • 20. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F, Trimarco B, Petretta M, Ferrara N, Bonaduce D, Chiariello M, Condorelli M.
    G Ital Cardiol; 1978 Jun 15; 8(8):861-7. PubMed ID: 359398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.